CAMBRIDGE, Mass., July 8, 2024 /PRNewswire/ -- Today Athinia® announced a collaboration with ASNA to combine unprecedented data sharing and traceability to improve critical semiconductor component and ...
An Alexion Pharmaceuticals Inc. patent describes new complement C1s subcomponent (C1S) inhibitors potentially useful for the treatment of immune thrombocytopenia purpura, lupus nephritis, amyotrophic ...
In my November 2024 column, I began discussing the building block approach for crashworthiness testing of composite structures. This approach features a multistep process for designing composite ...
In my two previous columns, I discussed the lower and intermediate levels of the building block approach for crashworthiness testing and analysis of composite structures. I focused on the commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results